baber/WOPTO huggingface dataset:
Patent NZ-595935-A (NZ)
Title: Headgear assembly for a respiratory mask assembly with upper and lower rear straps connected by angled upper and lower straps
Inventor: LITHGOW PERRY DAVID
IPC: A61M16/06
Filed: 2011-10-25
Abstract: 595935 Disclosed is a headgear assembly (16) for stabilizing and positioning a respiratory mask assembly on a patient's head. The assembly has a pair of side strap portions (18), each side strap portion including a pair of side straps (22, 24); and a rear strap portion (20) interconnecting the side strap portions and including an upper rear strap (26) and an intermediate strap (30) arrangement. The intermediate strap arrangement includes a pair of upper straps (32) extending downwardly and inwardly toward one another from the upper rear strap and a pair of lower straps (34) extending downwardly from the upper straps and outwardly away from one another. The upper rear strap has a curved portion of a predetermined radius, and the curved portion extends between and connects to the upper straps of the intermediate strap arrangement.
Patent NZ-598147-A (NZ)
Title: Mesoionic pesticides
Inventor: TONG MY-HANH THI
IPC: C07D401/06
Filed: 2009-01-30
Abstract: Disclosed are pyrimidinium compounds as represented by the general formula (I), wherein: X is O; Y is O; R1 is phenyl, naphthalenyl or a heteroaromatic mono or bicyclic ring system, which may be further substituted; R2 is alkyl, haloalkyl or CR5R6CH2OR21; R3 and R4 are alkyl or haloalkyl, or R3 and R4 may be taken together to form an optionally substituted heterocyclic or heteroaryl ring system, such as a pyridine or thiazole ring system; and wherein the remaining substituents are as defined herein. Representative compounds include 3-(2,4-difluorophenyl)-2-hydroxy-4-oxo-1-(2,2,2-trifluoroethyl)-4H-pyrido[1,2-a]pyrimidinium inner salt; 3-(4-fluorophenyl)-2-hydroxy-4-oxo-1-(2,2,2-trifluoroethyl)-4H-pyrido[1,2-a]pyrimidinium inner salt; and 2-hydroxy-4-oxo-3-phenyl-1-(2,2,2-trifluoroethyl)-4H-pyrido[1,2-a]pyrimidinium inner salt. Further disclosed is a composition which comprises a parasiticidally effective amount of compound as defined above, and at least one carrier for protecting an animal from an invertebrate parasitic pest. Also disclosed is a seed which has been treated with a compound as defined above.
Patent NZ-599265-A (NZ)
Title: A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
Inventor: KWON DONG-YEUL
IPC: A61K9/06
Filed: 2010-10-15
Abstract: 599265 Disclosed herein is a skin external composition comprising a combination of a salt, specifically sodium chloride, and a sugar, specifically glucose, as an active ingredient in an amount effective to treat or prevent vaginosis, together with a pharmaceutically acceptable carrier and the use thereof.
Patent NZ-601028-A (NZ)
Title: Dialysate regeneration system with external wall having material that passes gas but not liquid.
Inventor: GURA VICTOR
IPC: A61M1/16
Filed: 2012-07-03
Abstract: A dialysate regeneration system is disclosed with urease, a dialyzer, and a housing with an external wall, where the external wall is exposed to atmosphere and comprises a material that passes gas but does not pass liquid and where the housing is positioned between the urease and dialyzer.
Patent NZ-609803-A (NZ)
Title: A2a antagonists as cognition and motor function enhancers
Inventor: BANDAK STEPHEN I
IPC: A61P25/28
Filed: 2011-11-04
Abstract: Provided are methods of treating Parkinson’s disease or Parkinsonism by administering an adenosine A2a receptor antagonist in combination with a dopamine precursor or a dopamine receptor agonist. A preferred adenosine A2a receptor antagonist is 4-hydroxy-4-methylpiperidine-1-carboxylic acid-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide. A preferred dopamine precursor is levodopa and preferred dopamine receptor antagonists are apomorphine pramipexole, bromocriptine, cabergoline, ropinirole or rotigotine. Provided are methods of treating cognition impairment or decline or of enhancing cognition by administering 4-hydroxy-4-methylpiperidine-1-carboxylic acid-(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide.
Patent NZ-609972-A (NZ)
Title: Building foundation
Inventor: PRICE NEVILLE HOLMES
IPC: E04B5/17
Filed: 2012-05-14
Abstract: A foundation (1) for a building is disclosed. The foundation has a footing (2) assembled on site from a plurality of prefabricated footers (10, 50) rigidly connected together and supported by compacted ground below. The foundation is for a modular building that includes wall panels to be supported on the foundation. The footing is used to define a formwork that contains poured filler (24) of a settable material such a concrete, and is left as part of the foundation once cured.
Patent NZ-628803-A (NZ)
Title: A lock
Inventor: JABER HANI
IPC: E06B3/32
Filed: 2013-05-22
Abstract: A door or window locking assembly for sliding, bi-folding or concertina doors is described. The assembly seeks to reduce the risk of damage done to folding doors by protruding keys being left in locks by depressing the key into the handle. The assembly (100) includes a key barrel or cylinder (5) that when unlocked by a key (10), can be depressed, retracted or otherwise pushed in to the assembly. This allows the cylinder housing (2) to move along the axis of the key cylinder and thus the drive bracket (4) to be moved, transverse to the key cylinder, to disengage a latch bolt (6). The device optionally includes a handle (7) for sliding the bolt.
Patent NZ-701074-A (NZ)
Title: Mask system
Inventor: FORMICA JUSTIN JOHN
IPC: A61M16/06
Filed: 2011-09-30
Abstract: A mask system for delivery of respiratory therapy to a patient includes a nares portion and a mouth portion and an inlet conduit connected to at least one of the nares portion and the mouth portion to deliver the pressurized, breathable gas. The nares portion is adapted to form a seal with the wearer’s nares. The mouth portion including a mouth chamber and a sealing portion, the sealing portion adapted to form a seal with the wearer’s mouth. The mask system is adapted to selectively utilize the nares portion and/or the mouth portion. In a first mode the system utilises both the nares portion and the mouth portion, and in a second mode utilizes the nares portion and not utilizing the mouth portion. Also disclosed is a method of converting a respiratory mask system between said first and second modes.
Patent NZ-702025-A (NZ)
Title: Audio data transmission method
Inventor: LI DONGSHENG
IPC: H04M1/72433
Filed: 2013-06-17
Abstract: An audio data transmission method includes using a first device such as a mobile terminal for obtaining audio data to be transmitted. The first device modulates the audio data to be transmitted using at least two modulation modes respectively, wherein the modulation mode is an amplitude modulation, a frequency modulation, a carrier modulation or a subcarrier modulation. This generates audio data frame streams in the at least two modulation modes. The audio data frame streams are obtained by modulating the audio data to be transmitted into an analog waveform signal using the modulation modes of the first device so as to generate the audio data frame streams. The first device also splices the audio data frame streams in the at least two modulation modes into an audio data stream. The splicing is able to be without a time interval or with a time interval, and is undertaken to combine the analog waveforms that have been modulated using the at least two modulation modes. The audio data stream is transmitted to a second device in one transmission in the same time reference frame via an audio interface of the first device.
Patent NZ-709198-A (NZ)
Title: Modular store
Inventor: BISELLI GIANLUCA
IPC: F41A9/78
Filed: 2013-12-18
Abstract: Store (1) comprising a plurality of supplying modules (M), which define a plurality of rows, which are arranged one next to the other, each row having a predetermined number of crates (C); at least one flooring structure (2), which supports said supplying modules (M) and defines a walk-off surface; a moving system for a handler of said crates (C), which comprises a overhead-travelling-crane (3), which is arranged in the upper part of said supplying modules (M) and is adapted to move said handler in a reference plane (XY), so as to reach the single crates (C). Said overhead-travelling-crane (3) comprises a horizontal truss (30), which, in turn, comprises a carriage (32), to which said handler is fixed. Said horizontal truss (30) is adapted to slide along at least two longitudinal guides (31). Said longitudinal guides (31) are rigidly fixed to the supplying modules (M) of the external rows, which define the horizontal extension of the store. Each module (M) is rigidly fixed to said flooring structure (2). The Store is assembled in such a way that the elements making up the store itself are modular, this optimizing the space taken up. All the elements making up the store are structurally correlated with one another, reducing the positioning errors arising when objects are removed from or positioned into crates, compensating, in an optimal manner, the structural deformations of the store itself.
Patent NZ-710434-A (NZ)
Title: Tfpi inhibitors and methods of use
Inventor: HARTMANN RUDOLF
IPC: C40B40/10
Filed: 2011-02-11
Abstract: Disclosed is a method for identifying a TFPI-binding compound, the method comprising (a) contacting a peptide comprising TFPI Kunitz domain 1 (KD1) with a TFPI-binding peptide and a test compound under conditions that allow formation of KD1-TFPI-binding peptide complexes, wherein the TFPI-binding peptide comprising the structure as herein defined; (b) measuring KD1-TFPI-binding peptide complexes formed in step (a); and (c) comparing the number of KD1-TFPI-binding peptide complexes formed in the presence of the test compound with the number of KD1-TFPI-binding peptide complexes formed in the absence of the test compound, wherein a reduction in the number of KD1-TFPI-binding peptide complexes formed in the presence of the test compound compared to the number of KD1-TFPI-binding peptide complexes formed in the absence of the test compound indicates that the test compound is a TFPI-binding compound. Further disclosed is a method for identifying a TFPI-binding compound, the method comprising (a) contacting a peptide comprising TFPI Kunitz domain 1 (KD1) with a test compound, and (b) detecting binding of the test compound to a TFPI binding site defined by KD1 amino acid residues corresponding to human TFPI residues Phe28, Lys29, Ala30, Asp32, Ile46, Phe47, and Ile55.
Patent NZ-727689-A (NZ)
Title: Vista regulatory t cell mediator protein, vista binding agents and use thereof
Inventor: NOELLE RANDOLPH
IPC: A61P37/00
Filed: 2011-03-25
Abstract: Disclosed is the use of an agonistic anti-VISTA antibody, wherein said antibody elicits immunosuppressive effects on T cell immunity in the preparation of a composition treating or preventing an allergic condition.
Patent NZ-728086-A (NZ)
Title: Apparatuses and methods for enclosing a filling in a food product
Inventor: JENSEN MALLORY
IPC: A23K10/00
Filed: 2015-07-23
Abstract: A filling device comprises a modified vacuum-filling head that introduces a viscous filling, such as a gravy, into a loaf matrix in a retortable can so that the filling remains enclosed by the set loaf matrix after retorting. The filling can remain as a viscous gravy or can set as a gel, depending on the formulation of the filling. Preferably the viscous filling is distributed horizontally into the loaf matrix, for example through horizontally-facing apertures, during a pause in the descent of the can away from the filling device. The flow of the filling can be controlled by synchronized pneumatic valves.
Patent NZ-731287-A (NZ)
Title: Synthesis of copanlisib and its dihydrochloride salt
Inventor: PETERS JAN
IPC: C07D487/04
Filed: 2015-11-05
Abstract: The present invention relates to a novel method of preparing copanlisib, copanlisib dihydrochloride, or hydrates of copanlisib dihydrochloride, to novel intermediate compounds, and to the use of said novel intermediate compounds for the preparation of said copanlisib, copanlisib dihydrochloride, or hydrates of copanlisib dihydrochloride. The present invention also relates to copanlisib dihydrochloride hydrates as compounds.
Patent NZ-732371-A (NZ)
Title: Solid state forms of fused heteroaromatic pyrrolidinones
Inventor: CHEN RONGLIANG
IPC: A61P35/00
Filed: 2015-12-17
Abstract: Disclosed are chemical entities which are inhibitors of spleen tyrosine kinase (SYK), namely, chemical entities comprising 6-((1R,2S)-2-aminocyclohexylamino)-7-fluoro-4-(1 -methyl-1H- pyrazol-4-yl)-1H-pyrrolo[3,4-c]pyridine-3(2H)-one and certain solid state forms thereof. Also disclosed are methods of using the chemical entities to treat disorders such as a cancer.
Patent NZ-737399-A (NZ)
Title: Ccr2 modulators
Inventor: LUI REBECCA
IPC: A01N43/40
Filed: 2016-05-19
Abstract: Compounds are provided that are modulators of the CCR2 receptor. The compounds have the general formula (I) and are useful in pharmaceutical compositions, methods for the treatment of diseases and disorders involving the pathologic activtation of CCR2 receptors.
Patent NZ-743977-A (NZ)
Title: M hyo multivalent vaccine and uses thereof
Inventor: LAWRENCE PAULRAJ
IPC: A61K39/12
Filed: 2016-12-14
Abstract: The present invention relates to compositions or vaccines for combating Mycoplasma (M hyo), Porcine Circovirus type 2 (PCV2), and Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) infections in animals and for increasing the ability of pigs to gain weight and/or improve death loss, methods of vaccination against the infections, and kits for use with such methods and compositions. In particular, invention relates to compositions or vaccines comprising a Myo antigen, a modified-live PRRSV antigen, and a killed PRRSV antigen.
Patent NZ-759173-A (NZ)
Title: Antibacterial activity of galactooligosaccharide and xylitol in dermatological treatments
Inventor: MONTALDO IVAN
IPC: A61Q19/00
Filed: 2018-06-27
Abstract: The invention relates to topical formulations comprising: • a galactooligosaccharide; • 0.01 % to 10% w/w xylitol; and • a pharmaceutically or cosmetically acceptable carrier. The invention also relates to use of the formulations, and methods for their preparation.
Patent NZ-760615-A (NZ)
Title: Cleaning, healing and regeneration of tissue and wounds
Inventor: LEIGHTON TIMOTHY
IPC: A61C17/20
Filed: 2018-06-04
Abstract: An apparatus for treating human or animal tissue, the apparatus comprising a conical body defining a chamber, the conical body extending between a base of the conical body and an outlet nozzle of the conical body, wherein the base has an inlet for liquid flow into the chamber and the outlet nozzle is at a conical tip of the conical body and is configured to generate an output stream of liquid flow from the chamber for treating human or animal tissue, an acoustic transducer associated with the conical body and configured to introduce acoustic energy into the liquid within the chamber whereby the acoustic energy is present in the output stream, and a gas bubble generator configured for providing gas bubbles in the output stream that are configured to be excited by the acoustic energy, wherein the conical body and the nozzle thereof are configured to have pressure amplitude reflection coefficients with respect to the acoustic energy in liquid within the chamber of from -0.95 to -1.0, a liquid supply system adapted to supply a liquid flow through the inlet at a flow rate of from 0.1 to 7 litres/minute, the outlet nozzle is configured to generate an output stream of liquid flow having an average width of from 0.25 to 20 mm, the acoustic transducer is configured to generate acoustic energy having a frequency of from 0.1 to 5 MHz and the gas bubble generator is configured to provide in the output stream bubbles having a radius of from 0.5 to 40 µm, wherein at least one of the acoustic transducer and the gas bubble generator is configured to be controlled such that the frequency of the acoustic energy generated by the acoustic transducer is sufficient to produce non-inertial cavitation on bubble walls of the gas bubbles generated by the gas bubble generator. The invention is directed at minimizing energy usage.
Patent NZ-777755-A (NZ)
Title: Therapeutic use of trigonal glucagon/glp-1/gip receptor agonist or conjugate thereof for liver disease
Inventor: KIM JUNG KUK
IPC: A61P1/16
Filed: 2020-06-29
Abstract: The present invention relates to a therapeutic use, for liver disease, of a triple agonist having activity with respect to all of glucagon, GLP-1, and GIP receptors, or a long-acting conjugate thereof.
Patent PT-100680-A (PT)
Inventor: FOERSTER HARALD PROF DR MED
IPC: A61M1/28
Filed: 1992-07-10
Abstract: Described is a pharmaceutical preparation for use in peritoneal dialysis, in particular continuous ambulant peritoneal dialysis (CAPD). Also described is the use of a starch ester to prepare such a pharmaceutical preparation. Particularly suitable starch esters are acetyl starch with a mean molecular weight of 100,000 to 200,000 Daltons and a molar substitution ratio of 0.3 to 0.5. The preparations proposed make it possible to carry out peritoneal dialysis without damaging the peritoneal epithelium. Furthermore, the preparation is not stored in the organs of the body.
Patent PT-100872-A (PT)
Title: Methods and systems of compositions for control of the growth of microbial agents in aqueous media based on chlorine and glycoluryl
Inventor: JONES RONALD L
IPC: C02F/
Filed: 1992-09-17
Abstract: The present invention relates to methods and compositions for hygiene (cleansing) of aqueous media which combine a composition that is a chlorine source and a composition that is a glycoluryl source.  The method is essentially characterized in that a total available chlorine concentration effective for control of the growth of microbial agents and a glycoluryl concentration varying between about 0.1 and about 40.0 ppm, effective for stabilizing the total available chlorine, are maintained in the water.  The compositions are added together or separately, continuously or batchwise, and by any one of a series of methods.  The glycoluryl compound stabilizes the chlorine and prolongs its useful life as a microbicidal agent.
Patent PT-103686-A (PT)
Title: Sistema de alertas e localização de pessoas e bens, através de posicionamento global e tecnologias móveis
Inventor: LEITAO MARIA LUISA SIMOES SEMEDO PESTANA
IPC: H04W4/18
Filed: 2007-03-09
Abstract: O SISTEMA PERMITE ÀS AUTORIDADES POLICIAIS RECEBER E MONITORIZAR ALERTAS QUE CHEGUEM JÁ PROCESSADOS POR UMA APLICAÇÃO QUE INCORPORA UM SISTEMA DE INFORMAÇÃO GEOGRÁFICA. ESTA APLICAÇÃO DETERMINA O TIPO E LOCALIZAÇÃO DOS ALERTAS, MEDIANTE A INFORMAÇÃO VEICULADA ATRAVÉS DE REDES DE COMUNICAÇÕES (INTERNET E/OU REDES PRIVADAS) , RECEBIDA DE DISPOSITIVOS ACOPLADOS OU SITUADOS EM PESSOAS E BENS A PROTEGER, ASSIM COMO APRESENTA A INFORMAÇÃO NECESSÁRIA - LOCALIZAÇÃO EM MAPA, TIPO DE ALERTA, INFORMAÇÃO SOBRE A PESSOA OU BEM, TRAJECTO QUANDO APLICÁVEL - NUMA CONSOLA DE AGENTE. OS DISPOSITIVOS, APÓS ACCIONAMENTO POR UMA PESSOA, TÊM CAPACIDADE DE ENVIO PERIÓDICO DE MENSAGENS COM A RESPECTIVA LOCALIZAÇÃO, RECORRENDO A TECNOLOGIAS MÓVEIS. AS AUTORIDADES POLICIAIS TÊM A POSSIBILIDADE DE MONITORIZAR O SOM DO LOCAL DA OCORRÊNCIA, POR COMUNICAÇÕES DE NÚMEROS AUTORIZADOS ESTANDO VEDADAS CHAMADAS DE VOZ.
Patent PT-106274-A (PT)
Title: Gerador elétrico de eixo vertical
Inventor: ROSA FRANCISCO JOSE MARQUES DA CRUZ
IPC: F03D9/45
Filed: 2012-04-26
Abstract: O PRESENTE INVENTO É UM GERADOR ELÉTRICO DE EIXO VERTICAL, QUE TRANSFORMA A ENERGIA DO VENTO OU DAS CORRENTES HÍODRICAS EM ELETRICIDADE, SENDO INDÊNTICAS AS CARACTERÍSTICAS BÁSICAS DO GERADOR PARA AMBAS AS FONTES (EÓLICA OU HÍDRICA), POIS AMBOS UTILIZAM UM EIXO VERTICAL E EM TODAS O ACIONAMENTO É FEITO POR PÁS/TAMBORES DUPLOS DE CIRCULAÇÃO INVERSA, IMPULSIONANDO NUM SENTIDO AS CIRCULARES FIADAS DE IMANES (5,9) E NO OUTRO A FIADA DE BOBINES (12) CONFORME O DIRECIONAMENTO DAS LÂMINAS FIXAS (41) (42) DO DIRECIONADOR/ACELERADOR. O MOTOR É COMPOSTO PELOS DIRECIONADORES/ACELERADORES (30) (31) DE LÂMINAS FIXAS DIRECIONADAS (41) (42), E POR TAMBORES DE PÁS PROPULSADOS PELOS VENTOS OU PELAS CORRENTES HÍDRICAS DIRECIONADAS E ACELERADAS PELA ESTRUTURA DOS DIRECIONADORES/ACELERADORES (30) (31). PARA APROVEITAR A PRODUTIVIDADE OFERECIDA PELA CONCEÇÃO DO DÍNAMO (1,5,9,11,12), O QUAL PERMITE AS ROTAÇÕES INVERSAS DO INDUZIDO (11) ONDE ESTÃO AS BOBINES (12) E DO INDUTOR (1) ONDE ESTÃO OS ÍMANES (5,9), UTILIZAMOS DOIS MOTORES INVERTIDOS (30) (31) (UM RELATIVAMENTE AO OUTRO), O QUE PERMITE QUE UM MOTOR (30) IMPULSIONE A ROTAÇÃO DO INDUTOR (1) NUM SENTIDO E O OUTRO (31) IMPULSIONE A ROTAÇÃO DO INDUZIDO (1) NO SENTIDO INVERSO.
Patent RO-82966-A (RO)
Inventor: HOFMANN PETER
IPC: C07C69/24
Filed: 1981-12-08
Abstract: A method for preparing carboxylic acid alkylester after products free of nitrogen containing compounds. These after products, free of nitrogen containing compounds, are prepared by: (1) reacting olefins with carbon monoxide and alkanols in the presence of a catalyst system consisting of a cobalt compound and pyridine, non-orthosubstituted alkylpyridines or a mixture of these pyridines at elevated pressures and elevated temperatures to produce carboxylic acid alkylesters containing nitrogenated compounds resulting from the pyridines; (2) hydrogenating the carboxylic acid alkylesters to produce after products which include alcohols; and (3) treating the after products with acid ion exchangers to remove the nitrogenated compounds.
Patent RU-94007316-A (RU)
Inventor: TJUKAVKINA N A
IPC: A61K36/15
Filed: 1994-03-14
Abstract: FIELD: medicine; methods for extraction of arabinogalactane from larch wood. SUBSTANCE: method for extraction of arabinogalactane consists in that larch wood sawdust is subjected to extraction at ambient temperature with water (raw material-to-extracting agent ratio of (1:5)-(107) for 1.5 h. Filtered aqueous extract is boiled down to one half of the initial volume, cooled and with continuous stirring is added with one and one half volume of acetone with addition of 0.2-0.39 of sodium chloride (of aqueous extract). Decanted from arabinogalactane easily precipitated is supernatant liquid and arabinogalactane sediment is washed with acetone and dried. The offered method allows simple production from larch wood of arabinogalactane of high purity degree due to exclusion from the process of the stage of oxidation of phenol impurities and heating during precipitation. Duration of the process is reduced from 30 h according to that of the prototype down to 5.25 h with preserved quality of arabinogalactane. EFFECT: simplified method for extraction of arabinogalactane with preserved high purity degree of the product.
Patent RU-94017629-A (RU)
Inventor: CHERNENOK I V
IPC: B09C1/00
Filed: 1994-05-13
Abstract: FIELD: agriculture. SUBSTANCE: method involves determining soil contamination density and conducting presowing soil treatment, when soil contamination density is within the range of 1-25 Ki/sq.km; conducting presowing treatment of seed material by adding 200-400 g of bacterial preparation per hectare norm of crop seeds; applying mineral nitrogenous fertilizers in an amount of 20-40 kg/hectare of field. Seed material is treated by mixing for 15-20 min seed material, bacterial preparation and organic adhesive, with bacterial preparation and organic adhesive being taken in the ratio of 1:1 per hectare norm of crop seeds to be cultivated. EFFECT: increased efficiency in controlling penetration of radioactive nuclides into plants. 3 cl, 4 dwg, 5 tbl